Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9 | 1 | 8 | 8 | 9 |
| Receivables | N/A | N/A | N/A | 1 | 3 |
| Inventories | 700 | 715 | 724 | 724 | 721 |
| Other current assets | 0 | 0 | 2 | 0 | 0 |
| TOTAL | $709 | $717 | $733 | $735 | $740 |
| Non-Current Assets | |||||
| PPE Net | 9 | 12 | 16 | 17 | 19 |
| Intangibles | 81 | 97 | 113 | 1,115 | 1,174 |
| TOTAL | $90 | $109 | $129 | $1,132 | $1,193 |
| Total Assets | $799 | $826 | $862 | $1,867 | $1,933 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,105 | 3,078 | 3,082 | 2,901 | 2,627 |
| Accounts payable and accrued liabilities | 10 | 23 | 23 | 45 | 217 |
| Accrued Expenses | 1,370 | 1,305 | 1,240 | 1,175 | 1,110 |
| Other current liabilities | 92 | 81 | 70 | 408 | 405 |
| TOTAL | $4,577 | $4,487 | $4,577 | $4,549 | $4,397 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 21 | 38 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,577 | $4,487 | $4,577 | $4,549 | $4,397 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14 | 14 | 14 | 12 | 11 |
| Common Shares | 8 | 8 | 8 | 7 | 6 |
| Retained earnings | -13,064 | -12,947 | -13,001 | -11,784 | -11,428 |
| TOTAL | $-3,778 | $-3,661 | $-3,715 | $-2,682 | $-2,464 |
| Total Liabilities And Equity | $799 | $826 | $862 | $1,867 | $1,933 |